20/05/2015
First-in-human phase I study for SurgiMab’s molecule SGM-101 launched in Montpellier Cancer Institute.
17/04/2014
PhD Project 2014 “Design of a method for in silico maturation of antibodies”
08/04/2014
PhD Project 2014 “Modulation of the functions of human dendritic cells by Mabs specific of type C lectine receptors “
02/04/2014
PhD Project 2014 “Regulation of FcRn expression during tumorigenesis: Impact in the treatment with therapeutic antibodies”
02/04/2014
PhD Project 2014 “Identification of new targets involved in the Cetuximab molecular mechanism in colorectal cancer”
01/04/2014
PhD Project 2014 “Analysis of isoforms from the tyrosine kinase receptor HER4: towards a therapeutic targeting using isoform-specific antibodies in cancerology”
01/04/2014